儿童及青少年骨肉瘤诊疗规范(2019版)

2019-09-05 中华人民共和国国家卫生健康委员会 中华人民共和国国家卫生健康委员会官网

骨肉瘤(Osteosarcoma)是起源于间叶细胞恶性增殖产生骨样基质所构成的骨肿瘤,是最常见的原发性骨恶性肿瘤,多发生于骨骼快速生长发育的青少年或者儿童。 为进一步提高儿童血液病、恶性肿瘤诊疗规范化水平,保障医疗质量与安全,国家卫健委委托国家儿童医学中心组织专家对儿童血液病、恶性肿瘤相关10个病种诊疗规范进行了制修订,形成了相关病种诊疗规范(2019年版)。本文为儿童及青少年骨肉瘤诊疗规范(20

中文标题:

儿童及青少年骨肉瘤诊疗规范(2019版)

发布日期:

2019-09-05

简要介绍:

骨肉瘤(Osteosarcoma)是起源于间叶细胞恶性增殖产生骨样基质所构成的骨肿瘤,是最常见的原发性骨恶性肿瘤,多发生于骨骼快速生长发育的青少年或者儿童。 为进一步提高儿童血液病、恶性肿瘤诊疗规范化水平,保障医疗质量与安全,国家卫健委委托国家儿童医学中心组织专家对儿童血液病、恶性肿瘤相关10个病种诊疗规范进行了制修订,形成了相关病种诊疗规范(2019年版)。本文为儿童及青少年骨肉瘤诊疗规范(2019版)

 

拓展威廉亚洲博彩公司 :骨肉瘤相关威廉亚洲博彩公司 :

相关资料下载:
[AttachmentFileName(sort=100, fileName=儿童及青少年骨肉瘤诊疗规范(2019版))] GetToolGuiderByIdResponse(projectId=1, id=113b21c001e93812, title=儿童及青少年骨肉瘤诊疗规范(2019版), enTitle=, guiderFrom=中华人民共和国国家卫生健康委员会官网, authorId=null, author=, summary=骨肉瘤(Osteosarcoma)是起源于间叶细胞恶性增殖产生骨样基质所构成的骨肿瘤,是最常见的原发性骨恶性肿瘤,多发生于骨骼快速生长发育的青少年或者儿童。 为进一步提高儿童血液病、恶性肿瘤诊疗规范化水平,保障医疗质量与安全,国家卫健委委托国家儿童医学中心组织专家对儿童血液病、恶性肿瘤相关10个病种诊疗规范进行了制修订,形成了相关病种诊疗规范(2019年版)。本文为儿童及青少年骨肉瘤诊疗规范(20, cover=, journalId=null, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Thu Sep 05 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>骨肉瘤(Osteosarcoma)是起源于间叶细胞恶性增殖产生骨样基质所构成的骨肿瘤,是最常见的原发性骨恶性肿瘤,多发生于骨骼快速生长发育的青少年或者儿童。 为进一步提高儿童血液病、恶性肿瘤诊疗规范化水平,保障医疗质量与安全,国家卫健委委托国家儿童医学中心组织专家对儿童血液病、恶性肿瘤相关10个病种诊疗规范进行了制修订,形成了相关病种诊疗规范(2019年版)。本文为儿童及青少年骨肉瘤诊疗规范(2019版)</P> <P> </P>拓展威廉亚洲博彩公司 :<strong>与<font color=red>骨肉瘤</font>相关威廉亚洲博彩公司 :</strong><br><ul><li><a href="//www.nyrain.com/guideline/show_article.do?id=5e38f1c001e18a3c" title="四肢骨肉瘤保肢治疗威廉亚洲博彩公司 " target=_blank>四肢骨肉瘤保肢治疗威廉亚洲博彩公司 </a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=830f01c0016a9386" title="2018 ESMO/EURACAN临床实践威廉亚洲博彩公司 :骨肉瘤的诊断,治疗和随访" target=_blank>2018 ESMO/EURACAN临床实践威廉亚洲博彩公司 :骨肉瘤的诊断,治疗和随访</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=e57b91c001188304" title="2015 英国骨肉瘤管理威廉亚洲博彩公司 " target=_blank>2015 英国骨肉瘤管理威廉亚洲博彩公司 </a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=fc9991c001108ed2" title="2014 ESMO临床实践威廉亚洲博彩公司 :骨肉瘤的诊断,治疗和随访" target=_blank>2014 ESMO临床实践威廉亚洲博彩公司 :骨肉瘤的诊断,治疗和随访</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=df3101c0009a1074" title="2012 经典型骨肉瘤临床诊疗专家共识" target=_blank>2012 经典型骨肉瘤临床诊疗专家共识</a></li> 更多信息请点击:<a href="//www.nyrain.com/guideline/list.do?q=%E9%AA%A8%E8%82%89%E7%98%A4" target=_blank>有关骨肉瘤更多威廉亚洲博彩公司 </a></ul>, tagList=[TagDto(tagId=1496, tagName=骨肉瘤), TagDto(tagId=540, tagName=诊疗规范)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6341, appHits=391, showAppHits=0, pcHits=3624, showPcHits=3711, likes=98, shares=21, comments=5, approvalStatus=1, publishedTime=Sun Sep 22 22:20:55 CST 2019, publishedTimeString=2019-09-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Sep 22 22:20:55 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 12:32:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=儿童及青少年骨肉瘤诊疗规范(2019版))])
儿童及青少年骨肉瘤诊疗规范(2019版)
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1010774, encodeId=664e1010e7463, content=看不来, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb535280853, createdName=飞飞卡卡, createdTime=Mon Aug 23 22:44:33 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001373, encodeId=3db610013e395, content=?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200922/aa42c6291bb747bcbca39af7be0a43fe/56eacd48fd724813a1a0426e1e695c7c.jpg, createdBy=33165235027, createdName=147ab584m69暂无昵称, createdTime=Wed Jul 21 12:04:52 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001370, encodeId=cb3110013e0c5, content=。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200922/aa42c6291bb747bcbca39af7be0a43fe/56eacd48fd724813a1a0426e1e695c7c.jpg, createdBy=33165235027, createdName=147ab584m69暂无昵称, createdTime=Wed Jul 21 11:52:02 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2021-08-23 飞飞卡卡

    看不来

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1010774, encodeId=664e1010e7463, content=看不来, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb535280853, createdName=飞飞卡卡, createdTime=Mon Aug 23 22:44:33 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001373, encodeId=3db610013e395, content=?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200922/aa42c6291bb747bcbca39af7be0a43fe/56eacd48fd724813a1a0426e1e695c7c.jpg, createdBy=33165235027, createdName=147ab584m69暂无昵称, createdTime=Wed Jul 21 12:04:52 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001370, encodeId=cb3110013e0c5, content=。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200922/aa42c6291bb747bcbca39af7be0a43fe/56eacd48fd724813a1a0426e1e695c7c.jpg, createdBy=33165235027, createdName=147ab584m69暂无昵称, createdTime=Wed Jul 21 11:52:02 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2021-07-21 147ab584m69暂无昵称

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1010774, encodeId=664e1010e7463, content=看不来, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb535280853, createdName=飞飞卡卡, createdTime=Mon Aug 23 22:44:33 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001373, encodeId=3db610013e395, content=?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200922/aa42c6291bb747bcbca39af7be0a43fe/56eacd48fd724813a1a0426e1e695c7c.jpg, createdBy=33165235027, createdName=147ab584m69暂无昵称, createdTime=Wed Jul 21 12:04:52 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001370, encodeId=cb3110013e0c5, content=。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200922/aa42c6291bb747bcbca39af7be0a43fe/56eacd48fd724813a1a0426e1e695c7c.jpg, createdBy=33165235027, createdName=147ab584m69暂无昵称, createdTime=Wed Jul 21 11:52:02 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2021-07-21 147ab584m69暂无昵称

    0